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Abstract
Background: Coronaviruses have caused 3 outbreaks in the past 2 decades. The novel one 
is SARS-COV-2, which causes COVID-19.  Pregnant women have somewhat altered immune 
state, which may make them more vulnerable to COVID-19 and its complications. Extensive 
research is needed to better understand the clinical course of COVID-19 in this population.
Objective: This review article discusses the comparison of previous coronaviruses’ outbreaks, 
clinical presentations, and complications in pregnant women and newborns. 
Study Design: We conducted literature search for case series and case reports about preg-
nancy outcomes in pregnant women with COVID-19 during the early phase of pandemic.
Results: In case series, 37 of 129(28.6%) pregnant women with COVID-19 disease had pre-
term delivery and 14 of 67 pregnant women had fetal distress. The rate of preterm labor in 
normal pregnant women who are healthy and not infected with any virus worldwide is approx-
imately 11%.
Conclusion: Based on the articles reviewed, preterm delivery appears to be the most common 
complication in COVID-19 pregnant patients. Other complications include fetal distress, still-
birth, ICU admission and severe disease leading to fetal demise and maternal mortality. Preg-
nancy outcomes seem to be better with Covid-19 compared to SARs and MERS.  However, 
most of these publications are from the early part of the pandemic when protocols for care for 
pregnant women were being worked out and comprehensive knowledge of the disease process 
in pregnant women was still in developing stage.
Introduction
COVID-19 disease is caused by the SARS-CoV-2 virus which was first recognized in a 
cluster of pneumonia patients in China in December 2019. [1] As of early August 2020, 
infected cases are exceeding 20 million worldwide with more than 730 000 deaths. [2] 
Pregnant women’s health is an important issue which is still under addressed in this pan-
demic as well as in previous outbreaks of SARS and MERS. Pneumonia due to viral caus-
es may have higher mortality and morbidity during pregnancy. [1] Physiologic changes 
that occur during pregnancy are thought to affect pregnant women’s susceptibility to 
infection and clinical severity of illness. [1] Previous epidemics have demonstrated how 
pregnant women are more susceptible to infection and clinical severity, including the 
1918-1919 influenza pandemic and the 1957-1958 Asian flu epidemic. [1] The case fatality 
rate for the 1918-1919 influenza pandemic was 27% and even higher when exposure was 
in the 3rd trimester and the case fatality rate for the Asian flu epidemic was twice as high 
as for infected pregnant women compared to women who were not pregnant. [1] The 
Swine-origin influenza A (H1N1) virus also causes respiratory disease that also demon-
strated higher susceptibility in pregnant women. [3] In 2009, during the H1N1 epidemic, 
pregnant women were found to be at a higher risk of complications and were four times 
more likely to be hospitalized than the rest of the pregnant population. [3]
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This review article discusses the comparison of previous coronavirus outbreaks, clinical presentations, and complica-
tions in pregnant women and newborns.
Methods
On May 1st, 2020 we conducted a comprehensive literature search using PubMed and EMBASE. The search covered 
the articles on COVID-19 and pregnancy. The following combinations of terms were used to find the articles: COVID-19, 
COVID, pregnancy, maternal complications, and neonatal complications. From the search results, several case reports 
and series were identified. 
Inclusion criteria: Positive polymerase chain reaction (PCR) or chest tomography (CT) was used to confirm the diagno-
sis, the patient was pregnant at time of admission, article was written in English and clinical outcomes were mentioned. 
Exclusion criteria: Article is not a case series or case report, unable to obtain the full text, written in language other 
than English, COVID-19 suspected cases without PCR or CT confirmation or unreported clinical outcomes.
Results
Based on the results of the literature search, 9 case series and 6 case reports were included in this literature review. For 
easy interpretation case series and case reports were summarized separately. 
Case Series 
The clinical characteristics of mothers are reported in Table 1. Overall, the total number of patients included in the 
nine studies were 181. One hundred and thirty-three pregnant women were in the 3rd trimester, 26 in the 2nd trimester 
and 22 in the 1st trimester. The maternal age ranges from 23 years old to 40 years old with most of the patients below 
35 years old. The diagnosis was made using PCR, chest CT or both. CT findings included bilateral or unilateral patchy 
lung consolidation or ground glass opacities. Underlying comorbidities that presented before SARS-CoV-2 infection 
included vaginal bleeding, cholecystitis, polycystic ovary syndrome and others. Laboratory findings included maternal 
lymphopenia, elevated AST and ALT.
 
The maternal clinical outcomes are reported in Table 2. The most common reported complication in mothers was 
preterm delivery defined as delivery before 37 weeks’ gestational age which presented in 37 out of 129 patients (28.68%). 
The second most reported complication was fetal distress that was reported in 14 out of 67 patients (20.89%). Cesarean 
section (CS) is the most common reported mode of delivery (113/126 (89.68 %).
Lian Chen et al. reported 8 (57%) out of 14 preterm delivery to be iatrogenic. [4] Now it is established that COVID-19 
infection is not an indication for CS, and in fact it might increase the clinical deterioration in these patients. [5]
S. Hantoushzadeh et al. reported 9 severe cases that required intensive care unit (ICU) admission and mechanical ven-
tilation, death occurred in 7 patients. Out of those 7 patients, 5 experienced worsening of the disease after delivery. The 
other 2 had serious complications before delivery with intrauterine fetal death (IUFD). The only 2 living patients were 
still hospitalized at the study time, one achieved slow recovery and was extubated, but still hospitalized. The other one 
was still critically ill and intubated. [6] 
The neonatal outcomes are reported in Table 3. The most common complication reported in the neonates was low 
birth weight (LBW), defined as newborn birth weight < 2500 g, reported in 14 out of 49 neonates. LBW was seen with 
the preterm delivery (13/14 were preterm and 1/14 was full term). Other complications include stillbirth, rash and GI 
problems.  Admission to neonatal ICU and mechanical Ventilation (MV) were also reported.
Case Reports                 
We collected 6 studies with a total 8 patients and 8 neonates delivered.  Maternal age range was from 27 to 41. There 
were 3 twin sets with 2 sets delivered. All patients were in the 3rd trimester. More details about maternal characteris-
tics are mentioned in Table 4. Laboratory findings include lymphopenia in all patients, and elevated liver enzymes in 3 
out of 5 patients. There were no cases with gestational hypertension, preeclampsia or PROM.
The maternal and neonatal complications are reported in Table 5. The most common complication reported was 
preterm delivery in 5 of 8 patients. Intensive care unit (ICU) admission and mechanical ventilation occurred in 2 of 8 
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patients. Seven patients were delivered by cesarean section while one patient had a normal vaginal delivery. No mater-
nal mortality was reported.
There were 2 neonates admitted to a neonatal intensive care unit (NICU) with mechanical ventilation. One of them 
intubated due to excessive sedation to the mother. Those two neonates were born to the 2 mothers admitted to ICU. No 
stillbirth, LBW, neonatal asphyxia or death were reported.
Table 1. Maternal clinical characteristics




Maternal Lymphopenia (<1.0) ALT Elevated AST Elevated





 5 3 3
H. Zhu, et al21 9 25-35 3rd
Scarred uterus [1]




Y. Chen, et al22 4 23-34 3rd Cholecystitis [1] 2 0 0











NA 51/116 21/93 20/94
X. Hu, et al23 7 30-34 3rd 0 NA NA NA
Y. Liu, et al24 13 22-36 2nd (2)3rd (11) PROM (1) NA NA NA




















61/142 (42.96%) 29/120 (24.2%)
30/121 
(24.79%)
* The median age was 31 years.
**The author reported a 5-year range for each patient’s age to protect the patients’ identity.
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Table 2. Clinical outcomes in pregnant women with COVID-19





H. Chen, et al 9 0 4 2 CS 0 0 0
H. Zhu, et al 9 0 6 6 CS (7), NVD (2) 0 0 0
Y. Chen, et al 4 0 0 0 CS (3), NVD (1) 0 0 0
N. Yu, et al 7 0 0 0 CS (7) 0 0 0








NA CS (63), NVD (5) 1 NIMV 0
X. Hu, et al 7 0 0 0 CS (6), NVD (1) 0 0 0
Y. Liu, et al 13, Delivered (10) 0 6 3 CS (10) 1 ECMO (1) 0




Delivered (7) 0 7 3
CS (6), 
NVD (1) 9 IMV (9) 7



















H. Chen, et al 9 9 0 0 2 0 0
H. Zhu, et al 9 (1 twin pregnancy) 10 0 1 7 0 0
Y. Chen, et al 4 4 0 0 0 1 0
N. Yu, et al 7 7 0 0 0 0 0
L. Chen, et al 118 (2 Twin pregnancy) 70 0 0 NA NA NA
X. Hu, et al 7 7 0 0 0 0 0
Y. Liu, et al 13 9 1 0 NA NA NA
S. Chen, et al 5 5 0 0 0 0 0
S. Hantoushzadeh, 
et al
9 (3 Twin 
pregnancy) 6 4 2 5 1 1
Total 181 (6 Twin pregnancy) 127 5/187 (2.76%) 3/127 (2.36%) 14/49 (28.75%) 2/47 (4.26%) 1/47 (2.13%)
Table 3. Neonatal outcomes in pregnant women with COVID-19
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Fetal Distress Delivery Mode Neonatal ICU Neonatal MV
S. Iqbal, et al. 1 No No No NVD No No
H. Xia, et al. 1 No No Yes  CS No No
M. Alzamora, et al. 1 Yes Yes No CS Yes Yes
W. Schnettler, et al. 1 Yes Yes (ECMO) NO CS YES Yes
E. Koumoutsea, 
et al. Case 1 Yes No No CS No No
Case 2 Yes No Yes CS NA NA
C. Fan, et al. Case 1 No No No CS No No
Case 2 Yes No No CS No No
Total 5/8 2/8 2/8 CS 7/8, NVD 1/8 2/7 2/7
Table 5. Maternal and neonatal clinical outcomes
Study Author No. of Mothers Cases Maternal Age Neonate Delivered
Trimester at 
Admission Comorbidities
S. Iqbal, et al26 1 1 34 yes 3rd No
H. Xia, et al27 1 1 27 yes 3rd No
M. Alzamora, et al28 1 1 41 yes 3rd Diabetes mellitus
W. Schnettler, 









history of mild 
cerebrovascular 
accident
E. Koumoutsea,  








case 2 yes 3rd Asthma and obesity
C. Fan, et al31 2 case 1 34 yes 3rd No
case 2 29 yes 3rd No
Total 8 Cases 8
Table 4. Maternal clinical characteristics
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Discussion
The following are lessons from previous coronaviruses outbreaks:
Coronaviridae family
Coronaviridae is a large family that includes four genera of coronaviruses Alphacoronavirus, Betacoronavirus, Del-
tacoronavirus, and Gammacoronavirus. They are enveloped, single-stranded RNA viruses. They infect a wide range of 
birds, animals, and humans. There are seven species that cause human infection including endemic coronaviruses (4 
species), SARS, MERS and, recently, SARS-CoV-2. Their clinical manifestations range from mild to severe upper and 
lower respiratory disease. SARS and MERS caused significant outbreaks in 2002 and 2012 respectively. [1] SARS, MERS 
and SarS-CoV-2 are under the genus beta-coronavirus that might originate from bat virus. SARS-COV-2 shares 90% of 
the genetic material of bat virus while SARS shares 80 % and MERS 50%. [3] Therefore it is important to understand 
the effect of SARS and MERS on pregnancy during previous epidemics in order to help predict SARS-COV-2 behavior 
and guide the management of pregnancies until sufficient studies and data about the novel coronavirus are available.
Pregnancy complications of SARS and MERS
Limited data about pregnant women with SARS or MERS is available, so interpretation should be made wisely. SARS 
was associated with worse clinical outcomes in pregnant women than non-pregnant. [3] It caused several adverse 
events like spontaneous abortion, intrauterine growth restriction (IUGR) IUGR and severe maternal illness up to ma-
ternal death. [1] Maternal outcomes depended on the trimester of presentation. [7] Analysis suggests that pregnancy 
increases susceptibility to MERS and is associated with severe adverse outcomes with admission to ICU and death. [1] 
Mortality rate of SARS infection during pregnancy was 25% and even higher in MERS infection. [3] There is no vertical 
transmission noted in babies born to pregnant women infected with SARS or MERS. [1] SARS-COV-2 seems to follow 
the same path according to the available information although few cases of Covid-19 infection have been reported in 
neonates born to Covid-19 positive pregnant women. A large study was conducted in the UK on a national cohort of 
women in which they reported 12 (5%) of 256 infants tested positive for SARS-CoV-2 with 6 of them within the first 12 
hours of life. [8] Yet further investigation on vertical transmission is occurring to give more solid and accurate informa-
tion. 
Placental pathology of SARS
Only one study reported the pathology of placenta of mothers with SARS, which showed variable findings including in-
creased subchorionic fibrin, fetal thrombotic vasculopathy and areas of avascular chorionic villi. [9] These abnormali-
ties suggest placental malperfusion. Interestingly, the placenta appeared normal in pregnant women convalescing from 
SARS infection in the first trimester. This is in stark contrast to those infected in the third trimester, as they showed 
extensive placental pathology. [9] We did not find any available published study about placental pathology of mothers 
with MERS infection. 
Clinical presentation and complications of COVID-19
SARS-COV-2 has an average incubation period of about 5 days (2-14 days). [7] COVID -19 may present with fever, cough, 
dyspnea, anosmia, fatigue, nausea, loss of smell and taste, vomiting or diarrhea. Clinical presentation varies from as-
ymptomatic to flu-like symptoms, pneumonia, or ARDS and severe respiratory failure. [7] So far there is no evidence 
that pregnant women have increased risk for COVID-19. [10] There is no difference between pregnant and non-preg-
nant women in terms of clinical course. [11] Despite that, Liu H et al noted a difference in laboratory values and CT scan. 
They concluded an increase in leukocytosis and elevated neutrophil ratio in pregnant patients compared to non-preg-
nant adults. Also, complete consolidation and mixed consolidation with ground glass appearance were prevalent in 
pregnant cases in contrast to non-pregnant adults where pure ground glass appearance was common. [12] The obstetric 
complications which have been reported include miscarriage, preeclampsia, and cesarean section with preterm birth 
<37 weeks being the most common adverse event. [11] However, one study found very good outcomes of COVID-19 
pregnant patients whom acquired the infection in late pregnancy. [13] 
In our review, incidence of preterm delivery was 28.68% and the incidence of fetal distress was 20.9%. Not all preterm 
delivery was the result of fetal distress. Some of the preterm deliveries were due to maternal preference. The preterm 
delivery rate in the general population is 11%. [14] 
Although delivery through Cesarean section was reported as disproportionately high in these studies (89.6%), not all 
Cesarean sections were performed due to obstetric or fetal indications.  The early Chinese National Health commis-
sion guidelines favored CS to normal vaginal delivery (NVD) in COVID-19 cases due to fear and uncertainty about 
vertical transmission risk. [15] Some of the pregnant women with Covid-19 chose to be delivered before reaching term 
to proceed with further treatment for Covid-19 and/or to avoid prolonged labor which was thought to be potentially 
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detrimental for disease progression. Lack of knowledge, uncertainty about the potential harmful effect of Covid-19 to 
pregnant women and fetuses, psychological stress and panic surrounding the pandemic might have contributed to the 
high cesarean section rates and preterm deliveries. Even in the absence of Covid-19, cesarean sections due to maternal 
request are significantly higher in China compared to the United states. The incidence of cesarean delivery resulting 
from maternal request is estimated at 2.5% of all births in the United States. [16] A retrospective cohort study of 66,266 
patients in mode of delivery in China reported that 24.7% of women underwent cesarean delivery due to maternal re-
quest. [17] 
Another significant outcome seen in Covid-19 pandemic was low birth weight in (28.75%) of the babies born to preg-
nant women with Covid-19 disease. This number is like preterm delivery rate (28.68%) in these studies which partially 
explains the low birth weight.
Although these reports from the early pandemic show a grim outcome on cesarean section rates, preterm deliveries 
and low birth weight babies, a few more recent studies from New York have shown more positive results. A recent pro-
spective study including 241 Covid-19 positive pregnant women in New York Hospitals showed that the rate of cesarean 
birth was 41.5% (100) overall, but only 10 (10%) of the cesarean deliveries were performed for worsening maternal 
respiratory status. The incidence of preterm labor was 14.6% in this group of patients which is higher than worldwide 
average of 11%, but significantly less than preterm delivery rates reported earlier during the pandemic (28.6). [14] Fur-
thermore, a report on pregnant women with Covid-19 disease in New York that reported more than 1000 cases did not 
show significantly increased C-section rates. Their Cesarean section rate was 31% which is similar to national average. 
[18] 
ACOG guidelines recommend that Cesarean section should be reserved for obstetric indications and fetal indications, 
and that Covid-19 disease itself is not an indication for Cesarean section. [19] Adherence to ACOG guidelines has helped 
prevent not only unindicated preterm delivery and low birth weight babies but also morbidity related to Cesarean sec-
tion itself. Detection of asymptomatic and mildly symptomatic Covid-19 disease because of the availability of test kits, 
confidence of health care providers in taking care of these patients due to increasing information about the disease 
process also might explain less severe disease and better outcomes in these more recent studies.
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